Pages that link to "Q57300875"

The following pages link to Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics (Q57300875):

Displaying 29 items.

• Early life programming as a target for prevention of child and adolescent mental disorders (Q21245282) (← links)
• Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (Q24193032) (← links)
• A review of environmental contributions to childhood motor skills (Q26830011) (← links)
• Association Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis (Q34075005) (← links)
• Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development (Q34178991) (← links)
• Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review (Q34544981) (← links)
• The safety of antidepressant drugs during pregnancy (Q34661348) (← links)
• Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat? (Q35608913) (← links)
• SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome (Q36177632) (← links)
• The chemical erosion of human health: adverse environmental exposure and in-utero pollution - determinants of congenital disorders and chronic disease (Q36443893) (← links)
• Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. (Q36729123) (← links)
• Perinatal depression: treatment options and dilemmas. (Q36737979) (← links)
• The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring (Q36860205) (← links)
• Human teratogens: current controversies (Q37339099) (← links)
• Neurodevelopmental effects of prenatal exposure to psychotropic medications (Q37768121) (← links)
• Genetic basis of susceptibility to teratogen induced birth defects. (Q37902133) (← links)
• Management of Addiction Disorders in Pregnancy (Q37902483) (← links)
• Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy (Q38089714) (← links)
• Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review (Q38215072) (← links)
• Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study. (Q38660204) (← links)
• Child developmental outcomes in preschool children following antidepressant exposure in pregnancy. (Q39037107) (← links)
• Developmental outcomes of children exposed to antidepressants in pregnancy. (Q39783846) (← links)
• Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database (Q39846163) (← links)
• Motor and mental development of infants exposed to antiepileptic drugs in utero (Q46696643) (← links)
• Infant neurodevelopment following in utero exposure to antidepressant medication (Q48439912) (← links)
• Fetal Effects of In Utero Serotonin Reuptake Inhibitor (SRI) Antidepressant Exposure (Q58323855) (← links)
• Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis (Q61894772) (← links)
• Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers (Q64073001) (← links)
• Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications - A systematic review (Q91797135) (← links)